Administration Oral; Adult; Aged; Antimetabolites Antineoplastic; administration dosage; pharmacokinetics; Asian Continental Ancestry Group; statistics numerical data; Chi-Square Distribution; Clinical Trials; statistics numerical data; Drug Combinations; Europe; Female; Humans; Male; Middle Aged; Models Biological; Oxonic Acid; administration dosage; pharmacokinetics; Pyridines; administration dosage; pharmacokinetics; Statistics Nonparametric; Tegafur; administration dosage; pharmacokinetics; United States; Western World;
机译:口服抗癌药S-1在西方和日本患者中的药代动力学比较。
机译:口服抗癌药S-1在西方和日本患者中的药代动力学比较。
机译:用口服氟嘧啶抗癌患者泪液测定5-氟尿嘧啶和TEGAFUR,S-1
机译:单次口服后氟苯尼考在日本鳗鱼中的药代动力学
机译:对患者的1型多药抗性调节剂valspodar(PSC 833)和抗癌药阿霉素之间的治疗药物相互作用的药代动力学分析。
机译:Sipjeondaebo-Tang对通过群体药代动力学模型评估的大鼠S-1(一种抗癌药)的药代动力学的影响
机译:S-1,口服抗癌剂,西部和日本患者的药代动力学比较